Koers BrainsWay Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
BWAY
IL0011007189
Geavanceerde medische apparatuur & technologie
Omzet 2023 | 31,78 mln. 117 mln. 29,41 mln. | Omzet 2024 * | 37,78 mln. 139 mln. 34,96 mln. | Marktkapitalisatie | 90,72 mln. 334 mln. 83,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -4 mln. -14,73 mln. -3,7 mln. | Nettowinst (verlies) 2024 * | - 0 0 | EV/omzet 2023 | 3,31 x |
Nettoliquiditeiten 2023 * | - 0 0 | Nettoliquiditeiten 2024 * | - 0 0 | EV/omzet 2024 * | 2,4 x |
K/w-verhouding 2023 * |
-
| K/w-verhouding 2024 * |
-
| Werknemers | - |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 79,07% |
Recentste transcriptie over BrainsWay Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hadar Levy
CEO | Chief Executive Officer | 51 | 14-09-14 |
Yiftach Roth
FOU | Founder | 54 | 01-05-06 |
David Zacut
FOU | Founder | 72 | 07-11-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Josef Ben Shalom
BRD | Director/Board Member | 67 | 01-12-18 |
Karen Sarid
BRD | Director/Board Member | 73 | 03-12-17 |
Amiram Boehm
CHM | Chairman | 52 | 12-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,33% | 221 mld. | |
+7,20% | 184 mld. | |
+19,31% | 142 mld. | |
+18,70% | 101 mld. | |
+8,17% | 68,07 mld. | |
+25,25% | 57,27 mld. | |
-2,49% | 47,42 mld. | |
+6,01% | 43,19 mld. | |
+14,56% | 28,84 mld. |